High-risk HPV testing vs liquid-based cytology for cervical cancer screening among 25- to 30-year-old women: A historical cohort study.
Ohad FeldsteinHadar Gali-ZamirEduardo SchejterTali FeinbergEinav Yehuda-ShnaidmanJacob BornsteinTally LevyPublished in: Acta obstetricia et gynecologica Scandinavica (2022)
In women 25-30 years old, primary hrHPV screening was associated with a higher detection rate of CIN 3+ compared with cytology screening and should be considered for primary screening in this age group.